Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.

Cambridge, previously known as Cambridge Medical Communication, is committed to providing clear and imaginative medical communication materials for diverse target audiences within the healthcare industry. We pride ourselves on scientific expertise, and an astute attention to detail that gives our global client base confidence that we will deliver excellence.
Over more than 20 years, we have grown into an experienced and dedicated team of writers and editors, united in their passion for science, and driven by a common goal – to produce effective communication. Our wealth of experience means that we can provide a range of products from strategy development and meeting support to information sharing, and bespoke training.
Our commitment to supporting our clients as part of their team has paved the way for lasting relationships with individual medical professionals, as well as with large pharmaceutical companies. Cambridge is well-respected and our clients recommend us to their colleagues. We are adaptable and reliable, delivering on time, and within budget. As a team, we work hard to achieve success and to make our clients’ jobs easier.
Mantra.
Dedicated to excellence through inspirational scientific integrity, passion, and commitment.

Recent Highlights.
Spotlight on Jenny
Jenny Muiry PhD is the founder and Managing Director of Cambridge. The valued reputation of the agency is testament to Jenny’s analytical mindset and her drive for accuracy and clarity when communicating scientific content. Jenny has more than 25 years of experience within the medical communications industry. An early riser, Jenny walks the dogs, and then walks to work.

Vacancies.
We’re always looking for brilliant people to join our teams!
Click the link to find out more about becoming part of Prime Global, view available roles, and apply.
Join usInteresting Challenges.
Random Fact.
The two Scots, Jenny Muiry and Graeme Peterson, founded medical communications companies in the same year – 1998.
News.
-
Evolving applications of omics in healthcare
Prime Global 25 May, 2022 -
Haemophilia awareness: building trusted relationships between patients and industry
Prime Global 19 April, 2022Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
-
Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.
Get in touch.
We’re always happy to hear from you
Use the contact form or get full details for each of our offices around the world.